These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28026951)

  • 21. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
    Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
    J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
    Kashyap S; Singh N; Surnar B; Jayakannan M
    Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.
    Xu C; Wang P; Zhang J; Tian H; Park K; Chen X
    Small; 2015 Sep; 11(34):4321-33. PubMed ID: 26136261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and characterization of self-assembled nanoparticles based on low-molecular-weight heparin and stearylamine conjugates for controlled delivery of docetaxel.
    Kim DH; Termsarasab U; Cho HJ; Yoon IS; Lee JY; Moon HT; Kim DD
    Int J Nanomedicine; 2014; 9():5711-27. PubMed ID: 25525355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimetastatic effect of an orally active heparin derivative on experimentally induced metastasis.
    Lee DY; Park K; Kim SK; Park RW; Kwon IC; Kim SY; Byun Y
    Clin Cancer Res; 2008 May; 14(9):2841-9. PubMed ID: 18451252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.
    Song Q; Chuan X; Chen B; He B; Zhang H; Dai W; Wang X; Zhang Q
    Drug Deliv; 2016 Jun; 23(5):1734-46. PubMed ID: 25853477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
    Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
    J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorescent Copolymer-Based Prodrug for pH-Triggered Intracellular Release of DOX.
    Jia X; Zhao X; Tian K; Zhou T; Li J; Zhang R; Liu P
    Biomacromolecules; 2015 Nov; 16(11):3624-31. PubMed ID: 26461275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved antitumor activity and reduced myocardial toxicity of doxorubicin encapsulated in MPEG-PCL nanoparticles.
    Sun C; Zhou L; Gou M; Shi S; Li T; Lang J
    Oncol Rep; 2016 Jun; 35(6):3600-6. PubMed ID: 27109195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low Molecular Weight Heparin-Coated and Dendrimer-Based Core-Shell Nanoplatform with Enhanced Immune Activation and Multiple Anti-Metastatic Effects for Melanoma Treatment.
    Xia C; Yin S; Xu S; Ran G; Deng M; Mei L; Tang X; Rao J; Li M; Zhang Z; He Q
    Theranostics; 2019; 9(2):337-354. PubMed ID: 30809278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxorubicin conjugate of poly(ethylene glycol)-block-polyphosphoester for cancer therapy.
    Sun CY; Dou S; Du JZ; Yang XZ; Li YP; Wang J
    Adv Healthc Mater; 2014 Feb; 3(2):261-72. PubMed ID: 23852934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doxorubicin-induced co-assembling nanomedicines with temperature-sensitive acidic polymer and their in-situ-forming hydrogels for intratumoral administration.
    Wan J; Geng S; Zhao H; Peng X; Zhou Q; Li H; He M; Zhao Y; Yang X; Xu H
    J Control Release; 2016 Aug; 235():328-336. PubMed ID: 27282415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
    Wu J; Tang C; Yin C
    Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy.
    Chen L; Ji F; Bao Y; Xia J; Guo L; Wang J; Li Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):418-429. PubMed ID: 27770912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: In vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues.
    Sedlacek O; Monnery BD; Mattova J; Kucka J; Panek J; Janouskova O; Hocherl A; Verbraeken B; Vergaelen M; Zadinova M; Hoogenboom R; Hruby M
    Biomaterials; 2017 Nov; 146():1-12. PubMed ID: 28892751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-Propelled Gemini-like LMWH-Scaffold Nanodrugs for Overall Tumor Microenvironment Manipulation via Macrophage Reprogramming and Vessel Normalization.
    Xu C; Yang S; Jiang Z; Zhou J; Yao J
    Nano Lett; 2020 Jan; 20(1):372-383. PubMed ID: 31840517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zwitterionic mesoporous nanoparticles with a bioresponsive gatekeeper for cancer therapy.
    Khatoon S; Han HS; Lee M; Lee H; Jung DW; Thambi T; Ikram M; Kang YM; Yi GR; Park JH
    Acta Biomater; 2016 Aug; 40():282-292. PubMed ID: 27063494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and Fabrication of Multifunctional Sericin Nanoparticles for Tumor Targeting and pH-Responsive Subcellular Delivery of Cancer Chemotherapy Drugs.
    Huang L; Tao K; Liu J; Qi C; Xu L; Chang P; Gao J; Shuai X; Wang G; Wang Z; Wang L
    ACS Appl Mater Interfaces; 2016 Mar; 8(10):6577-85. PubMed ID: 26855027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs.
    Shim G; Kim JY; Han J; Chung SW; Lee S; Byun Y; Oh YK
    J Control Release; 2014 Sep; 189():80-9. PubMed ID: 24973719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.